Bolt Biotherapeutics Inc (BOLT)
1.14
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 13:25
Bolt Biotherapeutics Revenue (TTM): 7.876M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.876M |
| September 30, 2023 | 7.198M |
| June 30, 2023 | 6.782M |
| March 31, 2023 | 6.742M |
| Date | Value |
|---|---|
| December 31, 2022 | 5.729M |
| September 30, 2022 | 4.826M |
| June 30, 2022 | 3.466M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
3.466M
Minimum
Jun 2022
7.876M
Maximum
Dec 2023
6.088M
Average
6.742M
Median
Mar 2023
Revenue (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Ampio Pharmaceuticals Inc | -- |